Medications

Countering pharma's expensive gaming of the drug patent system

Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other entities ...

page 4 from 40